Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

Granulomatosis with polyangiitis (Wegener's): impact of maintenance therapy duration.

Springer J, Nutter B, Langford CA, Hoffman GS, Villa-Forte A.

Medicine (Baltimore). 2014 Mar;93(2):82-90. doi: 10.1097/MD.0000000000000020.

2.

Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.

Pagnoux C, Mahr A, Hamidou MA, Boffa JJ, Ruivard M, Ducroix JP, Kyndt X, Lifermann F, Papo T, Lambert M, Le Noach J, Khellaf M, Merrien D, Puéchal X, Vinzio S, Cohen P, Mouthon L, Cordier JF, Guillevin L; French Vasculitis Study Group..

N Engl J Med. 2008 Dec 25;359(26):2790-803. doi: 10.1056/NEJMoa0802311.

3.

Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis.

Puéchal X, Pagnoux C, Perrodeau É, Hamidou M, Boffa JJ, Kyndt X, Lifermann F, Papo T, Merrien D, Smail A, Delaval P, Hanrotel-Saliou C, Imbert B, Khouatra C, Lambert M, Leské C, Ly KH, Pertuiset E, Roblot P, Ruivard M, Subra JF, Viallard JF, Terrier B, Cohen P, Mouthon L, Le Jeunne C, Ravaud P, Guillevin L; French Vasculitis Study Group..

Arthritis Rheumatol. 2016 Mar;68(3):690-701. doi: 10.1002/art.39450.

4.
5.

Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience.

Villa-Forte A, Clark TM, Gomes M, Carey J, Mascha E, Karafa MT, Roberson G, Langford CA, Hoffman GS.

Medicine (Baltimore). 2007 Sep;86(5):269-77.

6.

Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.

Calich AL, Puéchal X, Pugnet G, London J, Terrier B, Charles P, Mouthon L, Guillevin L; French Vasculitis Study Group..

J Autoimmun. 2014 May;50:135-41. doi: 10.1016/j.jaut.2014.03.002. Epub 2014 Apr 2.

PMID:
24703438
7.

An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's).

Langford CA, Monach PA, Specks U, Seo P, Cuthbertson D, McAlear CA, Ytterberg SR, Hoffman GS, Krischer JP, Merkel PA; Vasculitis Clinical Research Consortium..

Ann Rheum Dis. 2014 Jul;73(7):1376-9. doi: 10.1136/annrheumdis-2013-204164. Epub 2013 Dec 9.

8.

Methotrexate plus leflunomide for the treatment of relapsingWegener's granulomatosis. A retrospective uncontrolled study.

Bremer JP, Ullrich S, Laudien M, Gross WL, Lamprecht P.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1 Suppl 57):67-71.

PMID:
20412706
9.

Deoxyspergualin in relapsing and refractory Wegener's granulomatosis.

Flossmann O, Baslund B, Bruchfeld A, Tervaert JW, Hall C, Heinzel P, Hellmich B, Luqmani RA, Nemoto K, Tesar V, Jayne DR.

Ann Rheum Dis. 2009 Jul;68(7):1125-30. doi: 10.1136/ard.2008.092429. Epub 2008 Aug 19.

PMID:
18713783
10.

[Treatment of ANCA-associated vascularitides].

Guillevin L, Pagnoux C.

Presse Med. 2007 May;36(5 Pt 2):922-7. Epub 2007 Apr 3. Review. French.

PMID:
17408912
11.

Etanercept plus standard therapy for Wegener's granulomatosis.

Wegener's Granulomatosis Etanercept Trial (WGET) Research Group..

N Engl J Med. 2005 Jan 27;352(4):351-61.

12.

Advances in the therapy of Wegener's granulomatosis.

Hellmich B, Lamprecht P, Gross WL.

Curr Opin Rheumatol. 2006 Jan;18(1):25-32. Review.

PMID:
16344616
13.

Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.

[No authors listed]

Prescrire Int. 2015 Jun;24(161):145-8. Review.

PMID:
26436161
14.

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniené J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C; European Vasculitis Study Group..

N Engl J Med. 2003 Jul 3;349(1):36-44.

15.

Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.

Metzler C, Miehle N, Manger K, Iking-Konert C, de Groot K, Hellmich B, Gross WL, Reinhold-Keller E; German Network of Rheumatic Diseases..

Rheumatology (Oxford). 2007 Jul;46(7):1087-91. Epub 2007 May 22.

PMID:
17519271
16.
17.
18.
19.

Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.

Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Ding L, Iklé D, Villareal M, Lim N, Brunetta P, Fervenza FC, Monach PA, Stone JH; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group..

Arthritis Rheumatol. 2015 Jun;67(6):1629-36. doi: 10.1002/art.39104.

20.

Long-term treatment of relapsing Wegener's granulomatosis with 15-deoxyspergualin.

Flossmann O, Jayne DR.

Rheumatology (Oxford). 2010 Mar;49(3):556-62. doi: 10.1093/rheumatology/kep411. Epub 2009 Dec 23.

PMID:
20032220

Supplemental Content

Support Center